19.15
price up icon6.21%   1.12
after-market アフターアワーズ: 18.38 -0.77 -4.02%
loading
前日終値:
$18.03
開ける:
$17.93
24時間の取引高:
285.48K
Relative Volume:
0.96
時価総額:
$1.62B
収益:
$14.09M
当期純損益:
$-176.94M
株価収益率:
-7.1852
EPS:
-2.6652
ネットキャッシュフロー:
$-141.24M
1週間 パフォーマンス:
+0.95%
1か月 パフォーマンス:
+5.10%
6か月 パフォーマンス:
-12.24%
1年 パフォーマンス:
+85.56%
1日の値動き範囲:
Value
$17.61
$19.20
1週間の範囲:
Value
$16.51
$19.20
52週間の値動き範囲:
Value
$8.64
$26.35

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name
名前
Newamsterdam Pharma Company Nv
Name
セクター
Healthcare (1182)
Name
電話
35 206 2971
Name
住所
GOOIMEER 2-35, NARRDEN
Name
職員
57
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
NAMS's Discussions on Twitter

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-01-18 開始されました Guggenheim Buy
2024-01-16 開始されました Piper Sandler Overweight
2023-10-30 開始されました RBC Capital Mkts Outperform

Newamsterdam Pharma Company Nv (NAMS) 最新ニュース

pulisher
04:09 AM

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Acquired by abrdn plc - MarketBeat

04:09 AM
pulisher
Nov 03, 2024

(NAMS) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 03, 2024
pulisher
Nov 01, 2024

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 01, 2024
pulisher
Oct 28, 2024

NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November - 24matins.uk

Oct 28, 2024
pulisher
Oct 25, 2024

Needham Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Buy Recommendation - MSN

Oct 25, 2024
pulisher
Oct 19, 2024

NewAmsterdam Pharma to Restate Prior Financials - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

NewAmsterdam Pharma to Restate Prior Financials By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 17, 2024

(NAMSW) Trading Report - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 14, 2024

NewAmsterdam Pharma Breaks Above 200-Day Moving AverageBullish for NAMS - Nasdaq

Oct 14, 2024
pulisher
Oct 12, 2024

Brokerages Set NewAmsterdam Pharma (NASDAQ:NAMS) Target Price at $33.80 - MarketBeat

Oct 12, 2024
pulisher
Oct 11, 2024

NewAmsterdam Pharma Company N.V. (NAMS) Price Target Increased by 8.93% to 31.11 - MSN

Oct 11, 2024
pulisher
Oct 11, 2024

Marshall Wace LLP Decreases Stake in NewAmsterdam Pharma (NASDAQ:NAMS) - MarketBeat

Oct 11, 2024
pulisher
Oct 07, 2024

When the Price of (NAMSW) Talks, People Listen - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 05, 2024

Millennium Management LLC Has $22.39 Million Stock Holdings in NewAmsterdam Pharma (NASDAQ:NAMS) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Obicetrapib Positions NewAmsterdam Pharma For Significant Market Growth In Cardiovascular Therapies - Seeking Alpha

Oct 04, 2024
pulisher
Oct 01, 2024

NewAmsterdam Pharma executive sells shares worth $707,400 - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

NewAmsterdam Pharma executive sells shares worth $707,400 By Investing.com - Investing.com UK

Oct 01, 2024
pulisher
Oct 01, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Down to $16.60 - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

NewAmsterdam Pharma Company NV (NAMS) rating initates by TD Cowen - Knox Daily

Oct 01, 2024
pulisher
Oct 01, 2024

Does NewAmsterdam Pharma Company NV (NAMS) offer a good opportunity for investors? - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Newamsterdam Pharma exec buys $17,332 in company stock By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 30, 2024

Newamsterdam Pharma exec buys $17,332 in company stock - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Sees Strong Trading Volume - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

TD Cowen Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Buy Recommendation - MSN

Sep 29, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Has $16.70 Million Position in NewAmsterdam Pharma (NASDAQ:NAMS) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Boosts Holdings in NewAmsterdam Pharma (NASDAQ:NAMS) - MarketBeat

Sep 25, 2024
pulisher
Sep 23, 2024

Investment opportunity in NewAmsterdam Pharma stock as anticipation builds for BROADWAY results By Investing.com - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Earns "Overweight" Rating from Piper Sandler - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Expert Ratings For NewAmsterdam Pharma - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Piper sees ‘attractive buying opportunity’ into NewAmsterdam data - TipRanks

Sep 23, 2024
pulisher
Sep 21, 2024

'She's A Hardy Filly': Ocean Club Goes All The Way On Front End In Noble Damsel - Paulick Report

Sep 21, 2024
pulisher
Sep 21, 2024

Ocean Club Skims to Narrow Victory in Noble Damsel - BloodHorse.com

Sep 21, 2024
pulisher
Sep 21, 2024

Ocean Club, in quick turnaround, holds off Five Towns, Breath Away to take Noble Damsel - Daily Racing Form

Sep 21, 2024
pulisher
Sep 21, 2024

Trend Tracker for (NAMS) - Stock Traders Daily

Sep 21, 2024
pulisher
Sep 19, 2024

Next shares rise on upbeat full-year profit outlook By Investing.com - Investing.com Australia

Sep 19, 2024
pulisher
Sep 19, 2024

UK's Next raises forecast to put 1 billion pound profit in sight - Reuters

Sep 19, 2024
pulisher
Sep 17, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Sep 17, 2024
pulisher
Sep 07, 2024

While institutions own 29% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), private equity firms are its largest shareholders with 47% ownership - Yahoo Finance

Sep 07, 2024
pulisher
Sep 05, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Earns "Outperform" Rating from Royal Bank of Canada - MarketBeat

Sep 05, 2024
pulisher
Sep 01, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Short Interest Up 20.7% in August - MarketBeat

Sep 01, 2024
pulisher
Aug 30, 2024

NAMSWNewAmsterdam Pharma Company N.V. Warrant Latest Stock News & Market Updates - StockTitan

Aug 30, 2024
pulisher
Aug 30, 2024

Buying Buzz: NewAmsterdam Pharma Company NV [NAMS] Chief Executive Officer Davidson Michael H. purchases 5,000 shares of the company – Knox Daily - Knox Daily

Aug 30, 2024
pulisher
Aug 30, 2024

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - Yahoo Finance

Aug 30, 2024
pulisher
Aug 29, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume - MarketBeat

Aug 29, 2024
pulisher
Aug 28, 2024

NewAmsterdam Pharma's Cholesterol Drug To See Blockbuster Sales, Bullish Analyst Sees Massive Upside - Benzinga

Aug 28, 2024
pulisher
Aug 28, 2024

NewAmsterdam Pharma (NASDAQ:NAMS) Now Covered by Analysts at Needham & Company LLC - MarketBeat

Aug 28, 2024
pulisher
Aug 27, 2024

NewAmsterdam shares hold Buy rating on strong trial data - Investing.com

Aug 27, 2024
pulisher
Aug 27, 2024

NewAmsterdam Pharma Company NV (NAMS)’s Market Momentum: Closing Strong at 16.76, Up 3.08 - The Dwinnex

Aug 27, 2024
pulisher
Aug 26, 2024

You might want to take a look at NewAmsterdam Pharma Company NV (NAMS) now - SETE News

Aug 26, 2024
pulisher
Aug 23, 2024

The Future of NewAmsterdam Pharma Company NV: Analyzing NAMS - The InvestChronicle

Aug 23, 2024
pulisher
Aug 23, 2024

NewAmsterdam Pharma Company NV [NAMS] is 47.99% higher this YTD. Is it still time to buy? - The DBT News

Aug 23, 2024

Newamsterdam Pharma Company Nv (NAMS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):